logo
Sign in

HLTRF Stock Price, Chart, Stats & News

HLS Therapeutics Inc. (HLTRF) does not currently pay a dividend.

87.26M
Market cap
–
Current P/E
31.95x
Forward P/E

HLTRF chart

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

HLS Therapeutics Inc. is a specialized pharmaceutical firm engaged in the acquisition and commercialization of medicinal products, with a primary focus on the central nervous system (CNS) and cardiovascular (CV) therapeutic areas. The company's activities extend across Canada, the United States, and international territories. Its core product lineup features Clozaril, an atypical antipsychotic medication prescribed for schizophrenia; Vascepa, composed of icosapent ethyl capsules; and PERSERIS, an injectable risperidone formulation also employed in the treatment of schizophrenia.

Similar securities

Based on sector and market capitalization

Report issue